NO984760D0 - Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction - Google Patents

Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction

Info

Publication number
NO984760D0
NO984760D0 NO984760A NO984760A NO984760D0 NO 984760 D0 NO984760 D0 NO 984760D0 NO 984760 A NO984760 A NO 984760A NO 984760 A NO984760 A NO 984760A NO 984760 D0 NO984760 D0 NO 984760D0
Authority
NO
Norway
Prior art keywords
osmolyte
inflammation
infection
treatment
effects caused
Prior art date
Application number
NO984760A
Other languages
Norwegian (no)
Other versions
NO984760L (en
Inventor
Dieter Houssinger
Original Assignee
Dieter Houssinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Houssinger filed Critical Dieter Houssinger
Publication of NO984760D0 publication Critical patent/NO984760D0/en
Publication of NO984760L publication Critical patent/NO984760L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
NO984760A 1996-04-12 1998-10-12 Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction NO984760L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (en) 1996-04-12 1996-04-12 New therapeutic treatment 1
PCT/EP1997/001862 WO1997038686A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction

Publications (2)

Publication Number Publication Date
NO984760D0 true NO984760D0 (en) 1998-10-12
NO984760L NO984760L (en) 1998-10-12

Family

ID=20402174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984760A NO984760L (en) 1996-04-12 1998-10-12 Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction

Country Status (7)

Country Link
EP (1) EP0910361A1 (en)
JP (1) JP2000508331A (en)
AU (1) AU2697197A (en)
CA (1) CA2251204A1 (en)
NO (1) NO984760L (en)
SE (1) SE9601395D0 (en)
WO (1) WO1997038686A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
JP2002532520A (en) * 1998-12-22 2002-10-02 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル Compounds and methods for airway disease treatment and airway drug delivery
US6926911B1 (en) 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
ES2233630T3 (en) * 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung USE OF COMPATIBLE SOLUTES AS SUBSTANCES WITH RADICAL SWEEPING PROPERTIES.
CA2386985A1 (en) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
EP1844006A2 (en) * 2005-01-05 2007-10-17 Magd Ahmed Kotb Abdalla Taurine synthesis, production and utility as a medicine
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
WO2006113978A2 (en) 2005-04-27 2006-11-02 Jallal Messadek Insulins combinations
JP2008537734A (en) * 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング Drugs containing compatible solutes for oral use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728444A (en) * 1971-04-28 1973-04-17 Stanley Drug Products Inc Method and compositions for inducing resistance to bacterial infections
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
TW282398B (en) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5516798A (en) * 1994-10-11 1996-05-14 North Carolina State University Method for treating diarrhea and a composition therefor

Also Published As

Publication number Publication date
WO1997038686A1 (en) 1997-10-23
SE9601395D0 (en) 1996-04-12
AU2697197A (en) 1997-11-07
JP2000508331A (en) 2000-07-04
CA2251204A1 (en) 1997-10-23
NO984760L (en) 1998-10-12
EP0910361A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
MX9204301A (en) ACILMERCAPTOALCANOILDIPEPTIDOS, METHODS OF PREPARATION AND ITS THERAPEUTIC USE.
FR2759581B1 (en) TREATMENT DEVICE, IN PARTICULAR WITH MOXA, OF THE ACUPRESSURE TYPE
TR199501560A2 (en) Gradually released caffeine formulation.
DK1181027T3 (en) Dietetic or pharmaceutical preparation for use in the prevention or treatment of hyperoxaluria
DE122009000012I1 (en) Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation.
ATE235481T1 (en) SUBSTITUTED BENZOPYRANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
PT877716E (en) BIOACTIVE GLASS COMPOSITIONS FOR USE IN THE TREATMENT OF DENTAL STRUCTURES
EE9700310A (en) Use of the R-enantiomer of N-propargyl-1-aminoindan, its salts and compositions
BR9508677A (en) Copolymer made of the same preparation and organic composition
NO984760D0 (en) Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction
KR100547921B1 (en) Sulfonamide-substituted chromamann, methods for the preparation thereof and pharmaceutical compositions comprising the same
EE04490B1 (en) The compound, its method of preparation and its use in medicine
GB9709360D0 (en) Methods for the treatment of herpes virus infections
BR9607967A (en) Use of immunomodular compositions extracted from bile to treat disorders of the immune system, manufacture of the drug and use of it
NO991459L (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
BR9506389B1 (en) silicon, and dietary, cosmetic and therapeutic composition.
TR199501501A2 (en) Preparation of the sugars.
NO992504L (en) Compositions for the treatment of soil, process for its preparation, and use
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
NO864718D0 (en) COSMETIC PREPARATION.
ITRM920305A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SHOCK, PARTICULARLY CARDIOGENIC SHOCK AND SEPTIC SHOCK.
GB9612990D0 (en) Compositions and methods for the treatment of chronic infections
ITRM950143A0 (en) USE OF 6,7-SUBSTITUTED 2-AMINOTETRALINES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS SUITABLE FOR THE TREATMENT OF SHOCK, AND OF ANTIPYRETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS.
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
AU2453697A (en) Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application